Siirry sisältöön

Neonatologia

Hyperbilirubinemian hoito

Valohoito

Randomised controlled trial of single phototherapy with reflecting curtains versus double phototherapy in term newborns with hyperbilirubinaemia. (avaa uuden ikkunan)

Abd Hamid IJ, M Iyen MI, Ibrahim NR, Abd Majid N, Ramli N, Van Rostenberghe H.

Lähde‎: J Paediatr Child Health 2013;49(5):375-9.

Arkistoitu‎: PubMed 23573836

DOI‎: 10.1111/jpc.12192

https://www.ncbi.nlm.nih.gov/pubmed/23573836 (avaa uuden ikkunan)

Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. (avaa uuden ikkunan)

Bhutani VK; Committee on Fetus and Newborn; American Academy of Pediatrics.

Lähde‎: Pediatrics 2011;128(4):e1046-52.

Arkistoitu‎: PubMed 21949150

DOI‎: 10.1542/peds.2011-1494

https://www.ncbi.nlm.nih.gov/pubmed/21949150 (avaa uuden ikkunan)

High-intensity phototherapy for the treatment of severe nonhaemolytic neonatal hyperbilirubinemia. (avaa uuden ikkunan)

de Carvalho M, Mochdece CC, Sá CA, Moreira ME.

Lähde‎: Acta Paediatr 2011;100(4):620-3.

Arkistoitu‎: PubMed 21251060

DOI‎: 10.1111/j.1651-2227.2011.02170.x

https://www.ncbi.nlm.nih.gov/pubmed/21251060 (avaa uuden ikkunan)

Efficacy of phototherapy for neonatal jaundice is increased by the use of low-cost white reflecting curtains. (avaa uuden ikkunan)

Djokomuljanto S, Quah BS, Surini Y, Noraida R, Ismail NZ, Hansen TW, Van Rostenberghe H.

Lähde‎: Arch Dis Child Fetal Neonatal Ed 2006;91(6):F439-42.

Arkistoitu‎: PubMed 16877479

DOI‎: 10.1136/adc.2006.095687

https://www.ncbi.nlm.nih.gov/pubmed/16877479 (avaa uuden ikkunan)

Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia. (avaa uuden ikkunan)

Gholitabar M, McGuire H, Rennie J, Manning D, Lai R.

Lähde‎: Cochrane Database Syst Rev 2012;(12):CD009017.

Arkistoitu‎: PubMed 23235669

DOI‎: 10.1002/14651858.CD009017.pub2

https://www.ncbi.nlm.nih.gov/pubmed/23235669 (avaa uuden ikkunan)

Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates. (avaa uuden ikkunan)

Kumar P, Chawla D, Deorari A.

Lähde‎: Cochrane Database Syst Rev 2011;(12):CD007969.

Arkistoitu‎: PubMed 22161417

DOI‎: 10.1002/14651858.CD007969.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22161417 (avaa uuden ikkunan)

Efficacy of phototherapy devices and outcomes among extremely low birth weight infants: multi-center observational study. (avaa uuden ikkunan)

Morris BH, Tyson JE, Stevenson DK, Oh W, Phelps DL, O'Shea TM, McDavid GE, Van Meurs KP, Vohr BR, Grisby C, Yao Q, Kandefer S, Wallace D, Higgins RD.

Lähde‎: J Perinatol 2013;33(2):126-33.

Arkistoitu‎: PubMed 22499082

DOI‎: 10.1038/jp.2012.39

https://www.ncbi.nlm.nih.gov/pubmed/22499082 (avaa uuden ikkunan)

Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants. (avaa uuden ikkunan)

Okwundu CI, Okoromah CA, Shah PS.

Lähde‎: Cochrane Database Syst Rev 2012;(1):CD007966.

Arkistoitu‎: PubMed 22258977

DOI‎: 10.1002/14651858.CD007966.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22258977 (avaa uuden ikkunan)

The effect of clofibrate with phototherapy in late pre-term newborns with non-hemolytic jaundice. (avaa uuden ikkunan)

Sakha SH, Gharehbaghi MM, Rahbani ME.

Lähde‎: Indian J Med Sci 2009;63(5):174-9.

Arkistoitu‎: PubMed 19584487

DOI‎: 10.4103/0019-5359.53162

https://www.ncbi.nlm.nih.gov/pubmed/19584487 (avaa uuden ikkunan)

A randomized trial of phototherapy with filtered sunlight in African neonates. (avaa uuden ikkunan)

Slusher TM, Olusanya BO, Vreman HJ, Brearley AM, Vaucher YE, Lund TC, Wong RJ, Emokpae AA, Stevenson DK.

Lähde‎: N Engl J Med 2015;373(12):1115-24.

Arkistoitu‎: PubMed 26376136

DOI‎: 10.1056/NEJMoa1501074

https://www.ncbi.nlm.nih.gov/pubmed/26376136 (avaa uuden ikkunan)

Dose-response relationship of phototherapy for hyperbilirubinemia. (avaa uuden ikkunan)

Vandborg PK, Hansen BM, Greisen G, Ebbesen F.

Lähde‎: Pediatrics 2012;130(2):e352-7.

Arkistoitu‎: PubMed 22802603

DOI‎: 10.1542/peds.2011-3235

https://www.ncbi.nlm.nih.gov/pubmed/22802603 (avaa uuden ikkunan)

Laskimoon annettava immunoglobuliini

High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. (avaa uuden ikkunan)

Alpay F, Sarici SU, Okutan V, Erdem G, Ozcan O, Gökçay E.

Lähde‎: Acta Paediatr 1999;88(2):216-9.

Arkistoitu‎: PubMed 10102158

https://www.ncbi.nlm.nih.gov/pubmed/10102158 (avaa uuden ikkunan)

High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease. (avaa uuden ikkunan)

Dağoğlu T, Ovali F, Samanci N, Bengisu E.

Lähde‎: J Int Med Res 1995;23(4):264-71.

Arkistoitu‎: PubMed 7589769

DOI‎: 10.1177/030006059502300406

https://www.ncbi.nlm.nih.gov/pubmed/7589769 (avaa uuden ikkunan)

Intravenous immune globulin reduces the need for exchange transfusions in Rhesus and ABO incompatibility. (avaa uuden ikkunan)

Huizing K, Røislien J, Hansen T.

Lähde‎: Acta Paediatr 2008;97(10):1362-5.

Arkistoitu‎: PubMed 18616629

DOI‎: 10.1111/j.1651-2227.2008.00915.x

https://www.ncbi.nlm.nih.gov/pubmed/18616629 (avaa uuden ikkunan)

Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. (avaa uuden ikkunan)

Miqdad AM, Abdelbasit OB, Shaheed MM, Seidahmed MZ, Abomelha AM, Arcala OP.

Lähde‎: J Matern Fetal Neonatal Med 2004;16(3):163-6.

Arkistoitu‎: PubMed 15590442

DOI‎: 10.1080/14767050400009873

https://www.ncbi.nlm.nih.gov/pubmed/15590442 (avaa uuden ikkunan)

Tinamesoporfyriini

Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia. (avaa uuden ikkunan)

Bhutani VK, Poland R, Meloy LD, Hegyi T, Fanaroff AA, Maisels MJ.

Lähde‎: J Perinatol 2016;36(7):533-9.

Arkistoitu‎: PubMed 26938918

DOI‎: 10.1038/jp.2016.22

https://www.ncbi.nlm.nih.gov/pubmed/26938918 (avaa uuden ikkunan)

Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant. (avaa uuden ikkunan)

Reddy P, Najundaswamy S, Mehta R, Petrova A, Hegyi T.

Lähde‎: J Perinatol 2003;23(6):507-8.

Arkistoitu‎: PubMed 13679941

DOI‎: 10.1038/sj.jp.7210943

https://www.ncbi.nlm.nih.gov/pubmed/13679941 (avaa uuden ikkunan)

Muut lääkeaineet

Effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy. (avaa uuden ikkunan)

Honar N, Ghashghaei Saadi E, Saki F, Pishva N, Shakibazad N, Hosseini Teshnizi S.

Lähde‎: J Pediatr Gastroenterol Nutr 2016;62(1):97-100.

Arkistoitu‎: PubMed 26020375

DOI‎: 10.1097/MPG.0000000000000874

https://www.ncbi.nlm.nih.gov/pubmed/26020375 (avaa uuden ikkunan)

Hyperbilirubinemia in the newborn infant > or =35 weeks' gestation: an update with clarifications. (avaa uuden ikkunan)

Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF.

Lähde‎: Pediatrics 2009;124(4):1193-8.

Arkistoitu‎: PubMed 19786452

DOI‎: 10.1542/peds.2009-0329

https://www.ncbi.nlm.nih.gov/pubmed/19786452 (avaa uuden ikkunan)

A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia. (avaa uuden ikkunan)

Mehta S, Kumar P, Narang A.

Lähde‎: J Pediatr 2005;147(6):781-5.

Arkistoitu‎: PubMed 16356431

DOI‎: 10.1016/j.jpeds.2005.07.026

https://www.ncbi.nlm.nih.gov/pubmed/16356431 (avaa uuden ikkunan)

Treatment of clofibrate in jaundiced low birth weight neonates. [English, Turkish abstract] (avaa uuden ikkunan)

Mohammadzadeh A, Farhat AS, Amiri R, Esmaely H, Bagheri S.

Lähde‎: UHOD-Uluslar Hematol Onkol De (Int J Hematol Oncol) 2009;19(2):100-5.

Arkistoitu‎: EMBASE 2009472903

http://www.uhod.org/summary_en.php3?id=359 (avaa uuden ikkunan)

Efficacy of clofibrate on severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial). (avaa uuden ikkunan)

Zahedpasha Y, Ahmadpour-Kacho M, Hajiahmadi M, Naderi S, Kamali AA.

Lähde‎: Southeast Asian J Trop Med Public Health 2008;39(3):557-61.

Arkistoitu‎: PubMed 18564698

https://www.ncbi.nlm.nih.gov/pubmed/18564698 (avaa uuden ikkunan)